Environmental pollutants and the rising burden of inflammatory bowel disease in East Asia: a narrative review.

Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis.

Transabdominal ultrasonography for small-bowel lesions in Crohn's disease: a prospective comparison with balloon-assisted enteroscopy.

Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn's disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years.

Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study.

Post-treatment simplified MaRIA score predicts clinical outcome in Crohn's disease patients.

Environmental pollutants and the rising burden of inflammatory bowel disease in East Asia: a narrative review.

Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis.

Transabdominal ultrasonography for small-bowel lesions in Crohn's disease: a prospective comparison with balloon-assisted enteroscopy.

Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn's disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years.

Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study.

Post-treatment simplified MaRIA score predicts clinical outcome in Crohn's disease patients.